Cargando…

Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis

Herpes simplex virus 1 (HSV) is a ubiquitous human virus resident in a majority of the global population as a latent infection. Acyclovir (ACV), is the standard of care drug used to treat primary and recurrent infections, supplemented in some patients with intravenous immunoglobulin (IVIG) treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramakrishna, Chandran, Mendonca, Stacee, Ruegger, Paul M., Kim, Jane Hannah, Borneman, James, Cantin, Edouard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410316/ https://www.ncbi.nlm.nih.gov/pubmed/32760124 http://dx.doi.org/10.1371/journal.pone.0237189

Ejemplares similares

Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection
por: Ramakrishna, Chandran, et al.
Publicado: (2017)

Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain
por: Ramakrishna, Chandran, et al.
Publicado: (2019)

Alopecia Following Oral Acyclovir for the Treatment of Herpes Simplex Keratitis
por: Sharma, Ashok, et al.
Publicado: (2014)

Neonatal Herpes Simplex Fulminant Hepatitis Successfully Treated with Acyclovir
por: Abuhasna, Said D., et al.
Publicado: (2012)

Necrotizing Keratitis Caused by Acyclovir-Resistant Herpes Simplex Virus
por: Toriyama, Koji, et al.
Publicado: (2014)

Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir
por: Enescu, Christina D., et al.
Publicado: (2021)

Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients
por: Mitterreiter, Johanna G., et al.
Publicado: (2016)

Herpes Simplex Encephalitis Complicated by Cerebral Hemorrhage during Acyclovir Therapy
por: Harada, Yukinori, et al.
Publicado: (2017)

Thrombocytopenia Secondary to Herpes Simplex Virus-2 Infection Successfully Treated by Acyclovir
por: Siddiqui, Raheel S, et al.
Publicado: (2020)

Hypertrophic herpes simplex virus 2 infection resistant to acyclovir in an immunosuppressed patient
por: Tan, Charlie, et al.
Publicado: (2023)

Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections
por: Al-Subaie, Mutlaq M, et al.
Publicado: (2015)

Acyclovir resistance in herpes simplex virus type I encephalitis: a case report
por: Bergmann, M., et al.
Publicado: (2016)

Clinical efficacy of oral and topical acyclovir in herpes simplex virus stromal necrotizing keratitis
por: Dutt, Surabhi, et al.
Publicado: (2016)

Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
por: Michaelis, Martin, et al.
Publicado: (2019)

Isolation, characterization and acyclovir susceptibility of herpes simplex virus isolates among immunocompromised patients
por: Nag, Soumyabrata, et al.
Publicado: (2021)

Presumed herpes simplex virus ulcerative nodular episcleritis treated by topical acyclovir alone
por: Hoshing, Abhishek, et al.
Publicado: (2022)

A Rare Case of Congenital Herpes Simplex Virus Infection with Therapeutic Response to Acyclovir
por: Jangid, Neha C., et al.
Publicado: (2023)

Implementation of In-house PCR Testing for Herpes Simplex Virus Encephalitis: Impact on Patient Acyclovir Exposure
por: Beaulieu, Ronald, et al.
Publicado: (2017)

Preparation and Evaluation of Novel In Situ Gels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections
por: Chaudhary, Binu, et al.
Publicado: (2014)

Empirical treatment with parenteral acyclovir in a child with herpes simplex virus hepatitis and acute lymphoblastic leukemia
por: Faqih, Nesreen A., et al.
Publicado: (2018)

Efficacy of acyclovir for herpes simplex encephalitis: A protocol for a systematic review of randomized controlled trial
por: Wang, Wei, et al.
Publicado: (2019)

1760. Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Hematologic Malignancies and Hematopoietic Cell Transplant
por: Ross, Justine Abella, et al.
Publicado: (2019)

Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity
por: Kalke, Kiira, et al.
Publicado: (2020)

609. Acute Kidney Injury During Treatment with Intravenous Acyclovir (AKITA) for Suspected Neonatal Herpes Simplex Virus Infection
por: Haltzman, Brittany L, et al.
Publicado: (2018)

Inactivation of acyclovir-sensitive and -resistant strains of herpes simplex virus type 1 in vitro by photodynamic antimicrobial chemotherapy
por: Latief, Miftahul Akhyar, et al.
Publicado: (2015)

The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2014)

Synergistic effects of acyclovir and 3, 19- isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains
por: Priengprom, Thongkoon, et al.
Publicado: (2015)

Impact of acyclovir use on survival of patients with ventilator-associated pneumonia and high load herpes simplex virus replication
por: Schuierer, Lukas, et al.
Publicado: (2020)

Role of Intravenous Acyclovir in Treatment of Herpes Simplex Virus Stromal Keratitis with Ulceration: A Review of 2 Cases
por: Pisitpayat, Punyanuch, et al.
Publicado: (2021)

Non-cytopathic herpes simplex virus type-1 isolated from acyclovir-treated patients with recurrent infections
por: Roy, Subrata, et al.
Publicado: (2022)

1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series
por: Albrecht, Kim WorkowskiJoerg, et al.
Publicado: (2021)

Efficacy of Acyclovir to Suppress Herpes Simplex Virus Oropharyngeal Reactivation in Patients Who Are Mechanically Ventilated: An Ancillary Study of the Preemptive Treatment for Herpesviridae (PTH) Trial
por: Luyt, Charles-Edouard, et al.
Publicado: (2021)

Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence
por: Omura, Natsumi, et al.
Publicado: (2017)

Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections
por: Birkmann, Alexander, et al.
Publicado: (2022)

Variant Analysis of the Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus in Korea: Frequency of Acyclovir Resistance Mutations
por: Hyun, Jungwon, et al.
Publicado: (2023)

Patterns of herpes simplex virus shedding over 1 month and the impact of acyclovir and HIV in HSV-2-seropositive women in Tanzania
por: Tanton, Clare, et al.
Publicado: (2011)

Silicone-Acyclovir Controlled Release Devices Suppress Primary Herpes Simplex Virus-2 and Varicella Zoster Virus Infections In Vitro
por: Berkower, Carol L., et al.
Publicado: (2013)

Acyclovir suppression to prevent recurrent genital herpes at delivery.
por: Scott, L L, et al.
Publicado: (2002)

Delayed Temporal Lobe Hemorrhage After Initiation of Acyclovir in an Immunocompetent Patient with Herpes Simplex Virus-2 Encephalitis: A Case Report
por: Mueller, Kyle, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d6sf2oi4fmh56rkpfltu4d59t9